SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,353 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr | ₹1,292 Cr |
What is the latest Total Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,353 Cr |
Mar2023 | ₹2,110 Cr |
Mar2022 | ₹1,967 Cr |
Mar2021 | ₹1,576 Cr |
Mar2020 | ₹1,292 Cr |
How is Total Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,353 Cr | 11.52 | |
Mar2023 | ₹2,110 Cr | 7.28 | |
Mar2022 | ₹1,967 Cr | 24.78 | |
Mar2021 | ₹1,576 Cr | 21.97 | |
Mar2020 | ₹1,292 Cr | - |
Compare Total Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹30,065.7 Cr | -6.9% | -7.5% | 75.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -6.9% |
-7.5% |
75.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses